Back to Search
NAUSHIN SIDDIQUI, M.D.
M.D.
Internal Medicine Physician
NPI: 1639224561IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
221632(NY)
Education
OTHER
Class of 1997
Research & Publications (20)
Disruption of the Arabidopsis SMC4 gene, AtCAP-C, compromises gametogenesis and embryogenesis.
PMID 16482433·Planta·2006
8-other
Mutations in Arabidopsis condensin genes disrupt embryogenesis, meristem organization and segregation of homologous chromosomes during meiosis.
PMID 12783798·Development·2003
8-other
Influence of limited proteolysis, detergent treatment and lyophilization on the phenoloxidase activity of Rapana thomasiana hemocyanin.
PMID 19426758·Int J Biol Macromol·2009
7-preclinical
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
PMID 19270277·Am J Trop Med Hyg·2009
5-case
Angiogenesis-a novel therapeutic approach for ischemic heart disease.
PMID 19623159·Mymensingh Med J·2009
6-review
Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening.
PMID 19565603·Arch Pharm (Weinheim)·2009
7-preclinical
Heart rate/blood pressure response and airway morbidity following tracheal intubation with direct laryngoscopy, GlideScope and Trachlight: a randomized control trial.
PMID 19417675·Eur J Anaesthesiol·2009
4-observational
Autoimmune haemolytic anaemia preceding the diagnosis of Hodgkin's disease: a report of two cases and review of the literature.
PMID 19438139·J Pak Med Assoc·2009
5-case
Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
PMID 19296983·J Urol·2009
4-observational
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India.
PMID 19436614·Ther Clin Risk Manag·2009
8-other
Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP.
PMID 19262567·EMBO J·2009
8-other
Design, synthesis, and in-vivo pharmacological screening of N,3-(substituted diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamide derivatives.
PMID 19194967·Arch Pharm (Weinheim)·2009
7-preclinical
Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus.
PMID 19182763·Mymensingh Med J·2009
6-review
Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.
PMID 19114552·Mol Cell Biol·2009
8-other
Involvement of glycans in the immunological cross-reaction between alpha-macroglobulin and hemocyanin of the gastropod Helix pomatia.
PMID 19167458·Biochimie·2009
7-preclinical
HIV and other sexually transmitted infections among men, transgenders and women selling sex in two cities in Pakistan: a cross-sectional prevalence survey.
PMID 19307351·Sex Transm Infect·2009
8-other
The eukaryotic translation initiation factor 4E (eIF4E) and HuR RNA operons collaboratively regulate the expression of survival and proliferative genes.
PMID 19287207·Cell Cycle·2009
6-review
Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options.
PMID 19124374·Ther Adv Respir Dis·2008
6-review
Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives.
PMID 19103578·Acta Pharm·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7729 141ST ST
FLUSHING, NY 11367 - Phone
- (718) 380-8810
Quick Facts
- NPI
- 1639224561
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile